Treating non-small cell lung cancer with selumetinib: an up-to-date drug evaluation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treating non-small cell lung cancer with selumetinib: an up-to-date drug evaluation

Published:2020-09-03 Issue:16 Volume:21 Page:1943-1953
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Imyanitov Evgeny N.¹²³⁴⁵,Levchenko Evgeny V.¹³,Kuligina Ekatherina S.¹,Orlov Sergey V.⁴⁵

Affiliation:

1. Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, St.-Petersburg, 197758, Russia

2. Department of Clinical Genetics, St.-Petersburg Pediatric Medical University, St.-Petersburg, 194100, Russia

3. Department of Oncology, I.I. Mechnikov North-Western Medical University, St.-Petersburg, 191015, Russia

4. Department of Oncology, I.P. Pavlov St.-Petersburg State Medical University, St.-Petersburg, 197022, Russia

5. Institute of Medical Primatology, Sochi, 354376, Russia

Funder

Russian Science Foundation

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2020.1798930

Reference90 articles.

1. MEK and the inhibitors: from bench to bedside

2. The MAPK pathway across different malignancies: A new perspective

3. MEK and PI3K inhibition in solid tumors: rationale and evidence to date

4. Compromised MAPK signaling in human diseases: an update

5. MEK inhibition in non-small cell lung cancer

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unravelling the role of tumor microenvironment responsive nanobiomaterials in spatiotemporal controlled drug delivery for lung cancer therapy;Drug Delivery and Translational Research;2024-07-22

2. A Review of the Molecular Determinants of Therapeutic Response in Non-Small Cell Lung Cancer Brain Metastases;International Journal of Molecular Sciences;2024-06-26

3. Investigation on the mechanism of Ranunculus ternatus Thunb. against esophageal squamous cell carcinoma based on network pharmacology and experimental verification;2024-05-08

4. Elaboration and validation of a prognostic signature associated with disulfidoptosis in lung adenocarcinoma, consolidated with integration of single-cell RNA sequencing and bulk RNA sequencing techniques;Frontiers in Immunology;2023-10-27

5. Drug repurposing based on differentially expressed genes suggests drug combinations with possible synergistic effects in treatment of lung adenocarcinoma;Cancer Biology & Therapy;2023-09-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3